F-MELACLEAR

F-MELACLEAR is formulated for skin affected by melasma and localized dark spots through a synergy of brightening actives. Tranexamic acid, the main component, inhibits UV-induced plasmin activity in keratinocytes, decreasing tyrosinase activity in melanocytes; it works with arbutin to inhibit tyrosinase, while glutathione brightens by converting melanin into a lighter form, niacinamide helps soothe irritation and regulates melanin production, and resorcinol provides gentle exfoliation and cellular renewal. Tranexamic acid mesotherapy is widely used in professional practice to help address melasma severity and even out skin tone. Daily use of Meso Shield 50 each morning is recommended, and caution is advised when treating the entire face to avoid over-lightening.

Recommended for you: F-VITAMIN C

• Helps improve the appearance of skin affected by melasma.
• Helps reduce the appearance of localized dark spots.

Apply via meso-needling, transdermal delivery devices, or post laser on face, neck, and décolleté. Use 1 to 3 ml per treatment (face and neck) with the nappage technique, targeting the epidermis (melanocytes). Initial course of 5 to 8 treatments with 2 weeks between sessions, then one treatment every 6 weeks as maintenance. Use daily Meso Shield 50 each morning; apply with caution on the entire face to avoid over-lightening.

• Niacinamide — Helps soothe irritation, reduces redness, and regulates melanin production, visibly diminishing the appearance of dark spots and hyperpigmentation.
• Tranexamic acid — Inhibits UV-induced plasmin activity and tyrosinase, helping reduce the appearance of pigmentation, brightening the skin, and fading the appearance of dark spots.
• Resorcinol — Provides gentle exfoliation, promoting cellular renewal and surface rejuvenation.
• Glutathione — Brightens the complexion by converting melanin into a lighter form while also inhibiting tyrosinase.
• Arbutin — Works synergistically with tranexamic acid to inhibit tyrosinase, the key enzyme in melanin synthesis.